theobromine has been researched along with alprostadil in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Just, M; Schlotte, V; Seiffge, D; Weithmann, KU | 1 |
| Breddin, K; Diehm, C; Gruss, JD; Heinrich, H; Horsch, S; Kriessmann, A; Maass, U; Martin, M; Trübestein, G; von Bary, S | 1 |
| Hori, M; Kikuchi, Y; Ohshima, N; Sakai, A | 1 |
| Ambrus, CM; Ambrus, JL; Dean, LS; Gastpar, H; Kahn, EA; Moore, RH; Reddington, MM; Schattman, GL; Taheri, P; Taheri, SA | 1 |
| Carandente, O; Di Perri, T; Guerrini, M; Messa, GL; Vittoria, A | 1 |
| Chiang, CP; Chiang, PH; Huang, CH; Shen, MR; Tsai, EM; Wu, CC; Wu, SN | 1 |
2 trial(s) available for theobromine and alprostadil
| Article | Year |
|---|---|
Intravenous prostaglandin E1 versus pentoxifylline therapy in chronic arterial occlusive disease--a controlled randomised multicenter study.
Topics: Aged; Alprostadil; Arterial Occlusive Diseases; Chronic Disease; Follow-Up Studies; Humans; Multicenter Studies as Topic; Pentoxifylline; Prospective Studies; Randomized Controlled Trials as Topic; Theobromine | 1989 |
Adenosine modulation of neurotransmission in penile erection.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Adult; Aged; Alprostadil; Animals; Antihypertensive Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Erectile Dysfunction; Humans; Male; Middle Aged; Muscle Contraction; Muscle, Smooth; Nitric Oxide; Norepinephrine; Penile Erection; Penis; Phenethylamines; Phenylisopropyladenosine; Purinergic P1 Receptor Agonists; Rabbits; Synaptic Transmission; Theobromine; Vasodilator Agents | 1994 |
5 other study(ies) available for theobromine and alprostadil
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Stimulatory effects of vascular prostaglandins on the antiaggregatory activities of pentoxifylline acetylsalicylic acid combinations in vitro.
Topics: Alprostadil; Aspirin; Drug Synergism; Epoprostenol; Humans; Pentoxifylline; Platelet Aggregation; Platelet Aggregation Inhibitors; Theobromine | 1989 |
Effects of pentoxifylline and prostaglandin E1 on cold blood perfusion studied by red blood cell deformability.
Topics: Alprostadil; Blood; Cold Temperature; Erythrocyte Deformability; Humans; Male; Micropore Filters; Pentoxifylline; Perfusion; Theobromine; Ultrafiltration | 1987 |
Red cell flexibility and platelet aggregation in patients with chronic obstructive vascular disease (COAD) and study of therapeutic approaches.
Topics: Adult; Aged; Alprostadil; Arterial Occlusive Diseases; Blood Viscosity; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pentoxifylline; Platelet Aggregation; Prostaglandins E; Smoking; Theobromine | 1984 |
Studies of the clinical pharmacology and therapeutic efficacy of pentoxifylline in peripheral obstructive arterial disease.
Topics: Alprostadil; Animals; Antifibrinolytic Agents; Arterial Occlusive Diseases; Blood Platelets; Drug Synergism; Fibrinolysis; Leg; Locomotion; Macaca; Male; Pentoxifylline; Prostaglandins E; Regional Blood Flow; Rheology; Theobromine; Urokinase-Type Plasminogen Activator | 1984 |